Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!
2024-2033 Oncolytic Virus Therapy Market: What Growth Rate is Predicted?
The scale of the oncolytic virus therapy market has experienced an explosive growth in the past years. Its value is projected to expand from $0.15 billion in 2023 to $0.19 billion in 2024, representing a compound annual growth rate (CAGR) of 26.2%. This significant rise during the historic period is credited to the enhancements in genetic engineering methods, heightened comprehension of the tumor microenvironment, clinical victories and regulatory approvals, the emergence of immunotherapy in the treatment of cancer, and progresses in gene delivery systems.
The market for oncolytic virus therapy is expected to experience significant growth in the coming years, with its value forecasted to reach $0.44 billion by 2028, growing at a compound annual growth rate (CAGR) of 23.9%. This projected growth for the forecast period is due to a number of factors including the proliferation of oncolytic virus platforms, combination therapies with immune checkpoint inhibitors, customised medical treatment strategies, the broadening of the clinical trial environment, as well as regulatory support and guidelines. The forecast period is also likely to witness key trends such as technological strides in delivery systems, progress in the field of synthetic biology, collaborations and alliances in the biopharmaceutical sector, advancements in virology and immunology, and a heightened focus on paediatric oncology.
Claim Your Free Sample of the Global Oncolytic Virus Therapy Market Report Today!
https://www.thebusinessresearchcompany.com/sample.aspx?id=12391&type=smp
What Aspects Are Driving the Expansion of the oncolytic virus therapy Market?
The rise in cancer incidences is anticipated to fuel the expansion of the oncolytic virus therapy market in the coming years. Cancer refers to a collection of diseases marked by unregulated cell growth and proliferation of abnormal cells throughout the body. Oncolytic virus therapy holds promise for selectively targeting and eliminating cancer cells while simultaneously triggering an immune response against the cancer, offering a double-action strategy for successful cancer treatment. For example, the American Cancer Society Inc., a non-profit organization based in the US, forecasted in January 2023 that there would be 609,820 cancer deaths and 1,958,310 new cancer diagnoses in the US in 2022. Hence, the rise in cancer incidences underpins the expansion of the oncolytic virus therapy market.
What Are the Significant Segments of the Oncolytic Virus Therapy Market?
1) By Therapy Type: HSV-Based Oncolytic Virus Therapy, Adenovirus-Based Oncolytic Virus Therapy, Reovirus, Poxviruses, NDV (Newcastle Disease Virus), Other Therapy Types
2) By Virus Type: Genetically Engineered Oncolytic Viruses, Oncolytic Wild-Type Viruses
3) By Application: Breast Cancer, Lung Cancer, Prostate Cancer, Melanoma, Brain Tumor, Blood Cancer
4) By End-User: Hospitals, Specialty Clinics, Cancer Research Institutes
What Trends Are Influencing the Evolution of the Oncolytic Virus Therapy Market?
Innovations in products are becoming a prominent trend in the oncolytic virus therapy market. Many of the leading companies in this market are concentrating on rolling out innovative products to consolidate their market position. In an instance from November 2021, Daiichi Sankyo Company Limited, a pharmaceutical corporation based in Japan, introduced DELYTACT in Japan. It is the inaugural oncolytic virus given approval for primary brain cancer in any area, inclusive of genetically engineered oncolytic herpes simplex virus type 1 (HSV-1). This virus specifically replicates and destroys tumor cells without impacting healthy tissues.
Order Now for Fast Delivery of Your Oncolytic Virus Therapy Market Report!
https://www.thebusinessresearchcompany.com/report/oncolytic-virus-therapy-global-market-report
Which Geographic Areas Are Influencing the Growth of the Oncolytic Virus Therapy Market?
North America was the largest region in the oncolytic virus therapy market in 2023, and is expected to be the fastest-growing region in the forecast period. The regions covered in the oncolytic virus therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The Oncolytic Virus Therapy Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the oncolytic virus therapy market, its market share, and analyzes key competitors along with their market positions.
The Table Of Content For The Oncolytic Virus Therapy Market Include
1. Oncolytic Virus Therapy Market Executive Summary
2. Oncolytic Virus Therapy Market Segments
3. Oncolytic Virus Therapy Market Size And Template Market Growth Rate
4. Key Oncolytic Virus Therapy Market Trends
5. Major Oncolytic Virus Therapy Market Drivers
……
25. Key Mergers And Acquisitions In The Oncolytic Virus Therapy Market
26. Top Oncolytic Virus Therapy Companies
27. Oncolytic Virus Therapy Market Opportunities And Strategies
28. Oncolytic Virus Therapy Market, Conclusions And Recommendations
29. Appendix
Discover Related Reports by The Business Research Company:
Stem Cell Therapy Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/stem-cells-therapy-global-market-report
Cell Therapy Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report
Cellular Immunotherapy Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/cellulars-immunotherapy-global-market-report
Learn More About The Business Research Company
The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
